607 related articles for article (PubMed ID: 6800048)
1. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
Glass F; Lippton H; Kadowitz PJ
Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
[TBL] [Abstract][Full Text] [Related]
2. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
3. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
4. Aggregation and inhibition of rat platelets, and the formation of endoperoxide metabolites.
Hwang DH
Prostaglandins Med; 1980 Sep; 5(3):163-73. PubMed ID: 7413850
[TBL] [Abstract][Full Text] [Related]
5. Effects of 2-indolecarbohydrazides on thromboxane synthetase activity and on in vitro and ex vivo blood platelet aggregation. New selective inhibitors.
Monge A; Erro A; Parrado P; Font M; Aldana I; Rocha E; Fernandez-Alvarez E
Arzneimittelforschung; 1986 Aug; 36(8):1184-6. PubMed ID: 3096343
[TBL] [Abstract][Full Text] [Related]
6. Effects of endothelin-1 on aggregation of normal and uremic platelets.
Pawlak K; Małyszko JS; Małyszko J; Myśliwiec M
Pol J Pharmacol; 1996; 48(2):185-90. PubMed ID: 9112649
[TBL] [Abstract][Full Text] [Related]
7. The role of prostaglandins in the ADP-induced aggregation of rabbit platelets shown by the use of 15-hydroxyprostaglandin dehydrogenase.
Wallis RB
Thromb Haemost; 1978 Jun; 39(3):725-32. PubMed ID: 705701
[TBL] [Abstract][Full Text] [Related]
8. [Role of arachidonic acid in platelet aggregation induced by S. typhimurium endotoxin].
Tur'ianov MKh; Lomazova KD; Kazanskaia LV; Chumakova ZV; Poliakova AM
Biull Eksp Biol Med; 1983 Sep; 96(9):33-5. PubMed ID: 6412781
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G
Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235
[TBL] [Abstract][Full Text] [Related]
10. Platelet prostaglandin production and its implications.
Smith JB; Ingerman CM; Silver MJ
Adv Prostaglandin Thromboxane Res; 1976; 2():747-53. PubMed ID: 983875
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1982 Jul; 222(1):276-81. PubMed ID: 7086705
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
Mevkh AT; Basevich VV; Varfolomeev SD
Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
[TBL] [Abstract][Full Text] [Related]
13. Endothelin and platelet function.
Ohlstein EH; Storer B; Nambi P; Given M; Lippton H
Thromb Res; 1990 Mar; 57(6):967-74. PubMed ID: 2116686
[TBL] [Abstract][Full Text] [Related]
14. Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation--role of arachidonic acid metabolism.
Caccese D; Praticò D; Ghiselli A; Natoli S; Pignatelli P; Sanguigni V; Iuliano L; Violi F
Thromb Haemost; 2000 Mar; 83(3):485-90. PubMed ID: 10744158
[TBL] [Abstract][Full Text] [Related]
15. [Studies on the inhibitory effect of etafenone hydrochloride on platelet aggregation].
Ujiie A; Komatsu H; Kubota T; Hamano S; Naito J
Nihon Yakurigaku Zasshi; 1983 Jun; 81(6):493-8. PubMed ID: 6618341
[TBL] [Abstract][Full Text] [Related]
16. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
[TBL] [Abstract][Full Text] [Related]
17. The effects of amrinone on human platelet aggregation: evidence that amrinone does not act through a cyclic nucleotide mechanism in platelet rich plasma.
Lippton HL; Horwitz PM; McNamara DB; Ignarro LJ; Landry AZ; Hyman AL; Kadowitz PJ
Prostaglandins Leukot Med; 1985 May; 18(2):193-204. PubMed ID: 3925461
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet function by polymorphonuclear leukocytes.
Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides.
Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK
Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
Le Breton GC; Lipowski JP; Feinberg H; Venton DL; Ho T; Wu KK
J Pharmacol Exp Ther; 1984 Apr; 229(1):80-4. PubMed ID: 6423815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
